Clasen et al¹ have commented in a letter on our study of cardiovascular disease after treatment of germ cell cancer. The risk of myocardial infarction during and shortly after treatment with bleomycin, etoposide, and cisplatin (BEP) is less than 1%.^1,2 Compared with the devastating consequences of progressive disease, this may be an acceptable and possibly unavoidable acute adverse effect of treatment. With the low number of incident cases of myocardial infarction during treatment, a risk model based on our cohort is difficult to construct.

中文翻译：

---

回复SC Clasen等。

Clasen等[ ^1]在一封信中评论了我们对生殖细胞癌治疗后心血管疾病的研究。博来霉素，依托泊苷和顺铂（BEP）治疗期间和治疗后不久的心肌梗塞风险小于1％。^1,2与进行性疾病的毁灭性后果相比，这可能是可接受的且可能不可避免的急性治疗不良反应。由于在治疗期间发生心肌梗死的病例较少，因此难以建立基于我们队列的风险模型。